3. Barbara Casadei, MD, DPhil, on Taking Risks and Shifting Focus

Why It Matters

Casadei’s leadership at a premier cardiology journal signals a push for innovative, policy‑driven research, influencing how cardiovascular science is disseminated and funded.

Key Takeaways

• Casadei appointed JAMA Cardiology Editor-in-Chief.
• Emphasizes risk‑taking for cardiovascular innovation.
• Shifts focus from clinical trials to health policy.
• Advocates interdisciplinary collaboration in cardiology research.
• Highlights mentorship's role in career evolution.

Pulse Analysis

Barbara Casadei’s elevation to Editor‑in‑Chief of JAMA Cardiology marks a watershed moment for the specialty. With a distinguished track record in clinical trials and guideline development, Casadei brings a clinician‑scientist’s perspective to a journal that shapes global cardiology discourse. Her appointment reflects a broader industry trend where leading physicians are tasked not only with publishing cutting‑edge data but also with curating content that bridges bedside care, public health, and emerging technologies.

In the podcast, Casadei emphasizes that calculated risk‑taking has been a catalyst throughout her career, from pioneering novel anticoagulant pathways to championing large‑scale outcome studies. She argues that the next frontier lies in marrying traditional trial methodology with real‑world evidence, health‑policy frameworks, and advanced analytics. By shifting editorial focus toward interdisciplinary research, she aims to accelerate translation of discoveries into practice, encouraging submissions that address equity, cost‑effectiveness, and implementation science alongside mechanistic insights.

The implications extend beyond academia. Pharmaceutical firms, device manufacturers, and health‑system leaders will look to JAMA Cardiology for guidance on emerging therapeutic landscapes and regulatory expectations. Casadei’s commitment to mentorship also signals a generational handoff, fostering a pipeline of diverse investigators equipped to navigate complex, data‑rich environments. As cardiovascular disease remains a leading cause of mortality, her vision for a more collaborative, policy‑aware research ecosystem could reshape funding priorities and accelerate innovations that improve patient outcomes worldwide.